Valeant Pharma (NYSE: VRX) says in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Management Changes Management Comments Rumors Short Sales Trader Talk

Valeant (VRX) Price Target Cut to $195 at Guggenheim; Thesis IntactNovember 6, 2015 6:29 AM Worst Case Valeant (VRX) is a Buy - MizuhoNovember 5, 2015 3:13 PM HedgEye says Valeant Pharma (VRX) may fall another 75%November 5, 2015 1:14 PM Three Reasons Valeant (VRX) is Plunging TodayNovember 5, 2015 12:02 PM